COYA   $6.43  5.76% Market Closed

Coya Therapeutics Inc
Total Cash 36.58M
totalCashPerShare 2.403
EBITDA -10.22M
Total Debt 0.00
quickRatio 9.561
currentRatio 10.427
Total Revenue 9.55M
debtToEquity
Revenue/Share 0.759
ROA -0.23549
ROE -0.41644
grossProfits
freeCashflow -4.42M
operatingCashflow -6.87M
earningsGrowth
revenueGrowth
grossMargins -0.14149
ebitdaMargins -1.06993
operatingMargins -0.94478
profitMargins -1.05707
enterpriseValue 73.47M
forwardPE -5.138686
floatShares 12.78M
sharesOutstanding 16.60M
sharesShort 186.09K
sharesShortPriorMonth 173.57K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.08%
heldPercentInstitutions 0.22%
Short Ratio help_outline 4.16%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 2.316
Price To Book help_outline 3.04
earningsQuarterlyGrowth
netIncomeToCommon -10.10M
trailingEps -0.74%
forwardEps -1.37%
enterpriseToEbitda -7.19
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.41 3Q 2024
institutionsCount 25
lastUpdated Nov. 2, 2024, 12:12 a.m.